Your browser doesn't support javascript.
loading
Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice.
Muik, Alexander; Lui, Bonny Gaby; Bacher, Maren; Wallisch, Ann-Kathrin; Toker, Aras; Couto, Carla Iris Cadima; Güler, Alptekin; Mampilli, Veena; Schmitt, Geneva J; Mottl, Jonathan; Ziegenhals, Thomas; Fesser, Stephanie; Reinholz, Jonas; Wernig, Florian; Schraut, Karla-Gerlinde; Hefesha, Hossam; Cai, Hui; Yang, Qi; Walzer, Kerstin C; Grosser, Jessica; Strauss, Stefan; Finlayson, Andrew; Krüger, Kimberly; Ozhelvaci, Orkun; Grikscheit, Katharina; Kohmer, Niko; Ciesek, Sandra; Swanson, Kena A; Vogel, Annette B; Türeci, Özlem; Sahin, Ugur.
Afiliación
  • Muik A; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Lui BG; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Bacher M; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Wallisch AK; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Toker A; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Couto CIC; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Güler A; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Mampilli V; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Schmitt GJ; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Mottl J; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Ziegenhals T; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Fesser S; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Reinholz J; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Wernig F; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Schraut KG; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Hefesha H; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Cai H; Pfizer, 401 N. Middletown Rd., Pearl River, NY 10960, USA.
  • Yang Q; Pfizer, 401 N. Middletown Rd., Pearl River, NY 10960, USA.
  • Walzer KC; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Grosser J; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Strauss S; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Finlayson A; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Krüger K; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Ozhelvaci O; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Grikscheit K; Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt am Main, Germany.
  • Kohmer N; Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt am Main, Germany.
  • Ciesek S; Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt am Main, Germany.
  • Swanson KA; DZIF-German Centre for Infection Research, External Partner Site, 60596 Frankfurt am Main, Germany.
  • Vogel AB; Pfizer, 401 N. Middletown Rd., Pearl River, NY 10960, USA.
  • Türeci Ö; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Sahin U; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
Sci Immunol ; 7(78): eade9888, 2022 12 23.
Article en En | MEDLINE | ID: mdl-36378074
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Animals / Humans Idioma: En Revista: Sci Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Animals / Humans Idioma: En Revista: Sci Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania